Ligand-specific regulation of transforming growth factor beta superfamily factors by leucine-rich repeats and immunoglobulin-like domains proteins

PLoS One. 2023 Aug 21;18(8):e0289726. doi: 10.1371/journal.pone.0289726. eCollection 2023.

Abstract

Leucine-rich repeats and immunoglobulin-like domains (LRIG) are transmembrane proteins shown to promote bone morphogenetic protein (BMP) signaling in Caenorhabditis elegans, Drosophila melanogaster, and mammals. BMPs comprise a subfamily of the transforming growth factor beta (TGFβ) superfamily, or TGFβ family, of ligands. In mammals, LRIG1 and LRIG3 promote BMP4 signaling. BMP6 signaling, but not BMP9 signaling, is also regulated by LRIG proteins, although the specific contributions of LRIG1, LRIG2, and LRIG3 have not been investigated, nor is it known whether other mammalian TGFβ family members are regulated by LRIG proteins. To address these questions, we took advantage of Lrig-null mouse embryonic fibroblasts (MEFs) with doxycycline-inducible LRIG1, LRIG2, and LRIG3 alleles, which were stimulated with ligands representing all the major TGFβ family subgroups. By analyzing the signal mediators pSmad1/5 and pSmad3, as well as the induction of Id1 expression, we showed that LRIG1 promoted BMP2, BMP4, and BMP6 signaling and suppressed GDF7 signaling; LRIG2 promoted BMP2 and BMP4 signaling; and LRIG3 promoted BMP2, BMP4, BMP6, and GDF7 signaling. BMP9 and BMP10 signaling was not regulated by individual LRIG proteins, however, it was enhanced in Lrig-null cells. LRIG proteins did not regulate TGFβ1-induced pSmad1/5 signaling, or GDF11- or TGFβ1-induced pSmad3 signaling. Taken together, our results show that some, but not all, TGFβ family ligands are regulated by LRIG proteins and that the three LRIG proteins display differential regulatory effects. LRIG proteins thereby provide regulatory means for the cell to further diversify the signaling outcomes generated by a limited number of TGFβ family ligands and receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Drosophila melanogaster*
  • Fibroblasts*
  • Immunoglobulin Domains
  • Leucine
  • Ligands
  • Mammals
  • Mice
  • Transforming Growth Factor beta
  • Transforming Growth Factors

Substances

  • Leucine
  • Ligands
  • Transforming Growth Factors
  • Transforming Growth Factor beta

Grants and funding

This research was supported by the Swedish Cancer Society (https://www.cancerfonden.se), contract number 21 1583 Pj, to HH; the Kempe Foundation (https://www.kempe.com), grant number JCK-1829, to HH; and the Lion’s Cancer Research Foundation at Umeå University (https://cancerforskningsfonden.se/), grant numbers LP 21-2276, LS 21-152, and LS 22-153, to HH; and by the regional agreement between Umeå University and Västerbotten County Council on cooperation in the field of Medicine, Odontology and Health, ALF, grant number RV-967035, to HH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.